InvestorsHub Logo
Followers 0
Posts 13277
Boards Moderated 0
Alias Born 05/06/2016

Re: None

Friday, 05/06/2016 4:12:24 PM

Friday, May 06, 2016 4:12:24 PM

Post# of 121643
MDIN blew the lactose deal like they've blown EVERYTHING else!

In 2013 MDIN bought the right to license a lactose supplement when the lactose formulation is ready for market.
Then they never mentioned it again, or gave any indication that a product was in development or that the company was working with Manzo Pharmaceuticals in any way.

In the intro above, it says "They acquired the non-exclusive right to use the patent in exchange for 400,000,000 shares and a 2% royalty on net profit. Subsequent filings indicate that the agreement was terminated. Some portion of the restricted shares were returned and the balance were changed to free-trading. Manzo Pharma. (MNZO, another Barton funded company) and Celprogen are working directly to try and develop this product."

Well, according to Kenneth Manzo himself, that's untrue and MDIN no longer has a valid license, nor are they working with Celprogen in any manner.
Kenneth Manzo has announced that his new lactose treatment will be available beginning late summer/early fall 2016.

Twitter 5/5/16
Lacto-Freedom probiotic production has begun.
If all goes well, I expect it to be available by August 2016.
https://twitter.com/ManzoPharma/status/728183200590274561




Two days ago I sent Ken an email:

Subject: Lacto-Freedom partner?

Message:
I see that LF is due to be released this year.

Will MedGen be involved in any way? It was announced 3 years ago that Northstar Global had acquired a patent license, so will they be marketing LF, or do they simply have the right to market their own competing product?
Since MedGen has done nothing but release lies for 3 years, that story is probably 100% bogus too.


I received this reply:

Subject: RE: Manzo Pharmaceuticals, Inc. Contact: Lacto-Freedom partner?
From: "Ken ." <manzopharma@outlook.com>
Date: Wed, May 4, 2016 8:33 am

Yes, I expect it to be released this August. Northstar's exploratory agreement has expired and I have not heard from them to renew it or license the probiotic since the human study.




So MDIN is left out in the cold with no lactose product to market. This was sure to be MDIN's biggest product ever, and they've completely failed to capitalize on the opportunity! Millions of shares wasted on NOTHING! EPIC FAIL!

Manzo will get his product to market long before any competing products that might be produced if more licenses are sold.

Anyone surprised? Didn't think so. Just more fraud in the neverending saga of MDIN FRAUD!